| Application no. and date | 19728294.0 (espacenet) (Federated) (European Patent Register), 20190517 | | Patent/reg. no. and date | DK/EP 3793613, 20250101 | | Publication date | 20210324 | | Priority no. and date | US 201862673015 P, 20180517, US 201862724259 P, 20180829 | | EP pub. no. and date |
EP 3793613 20210324 | | Effective date | | | Applicant/owner | The Board of Trustees of the Leland Stanford
Junior University, Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386
Stanford, CA 94305-2038, US,
Bolt Biotherapeutics, Inc., 900 Chesapeake Drive
Redwood City, CA 94063, US | | Applicant ref. no. | | | Inventor | ENGLEMAN, Edgar George, 60 Lane Place
Atherton, CA 94027, US,
JACKSON, David Y., 2764 Waltham Cross Street
Belmont, California 94002, US,
ALONSO, Michael N., 1109 Pomeroy Avenue
Santa Clara, California 95051, US,
SAFINA, Brian, 2104 Forest Ave.
Belmont, California 94002, US,
ACKERMAN, Shelley Erin, 2111 Latham St. 303
Mountain View, California 94040, US | | Representative | | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/32 (2006.01) | | Title | IMMUNOCONJUGATES | | Int. application no. | US2019032947 | | Int. publication no. | WO2019222676 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
